Development and analysis of pharmaceutical intermediates in China.
Column:Industry Trends Time:2016-12-09
Development and analysis of pharmaceutical intermediates in China.

At present, the industrial structure adjustment with a large multinational pharmaceutical company, multinational production and the international division of labor further refinement, our country has become the important intermediates in the pharmaceutical industry global division of labor production base.China's pharmaceutical intermediates industry has formed a complete system from research and development to production and sales.From the point of the development of pharmaceutical intermediates in the world, the technology level of our country is still relatively low, a large number of advanced pharmaceutical intermediates and less patent drug intermediates of form a complete set of products production enterprise, is in the midst of the product structure optimization and upgrading of development stage.

In China, the oversupply of pharmaceutical intermediates is prominent, and the dependence on exports is increasing.But China's exports are mainly concentrated in vitamin C, penicillin, acetaminophen, citric acid and its salts and esters, such as commodities, output the characteristics of the products is huge, production enterprises, the market competition is intense, product price and added value is low, the mass production of them caused the domestic pharmaceutical intermediates market oversupply situation.High-technology products still rely heavily on imports.

For the protection of amino acid pharmaceutical intermediates, most of the products in domestic production enterprises are single, and the quality is unstable, which is mainly customized for foreign biopharmaceuticals companies.Only some enterprises with strong research and development strength, advanced production facilities and large-scale production experience can obtain high profits in the competition.